Cost of Revenue of Co-Diagnostics, Inc. from 30 Jun 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Co-Diagnostics, Inc. quarterly and annual Cost of Revenue in USD history and change rate from 30 Jun 2017 to 30 Sep 2025.
  • Co-Diagnostics, Inc. Cost of Revenue for the quarter ending 30 Sep 2025 was $26,285, a 91% decline year-over-year.
  • Co-Diagnostics, Inc. Cost of Revenue for the twelve months ending 30 Sep 2025 was $335,049, a 91% decline year-over-year.
  • Co-Diagnostics, Inc. annual Cost of Revenue for 2024 was $999,124, a 76% decline from 2023.
  • Co-Diagnostics, Inc. annual Cost of Revenue for 2023 was $4,184,949, a 24% decline from 2022.
  • Co-Diagnostics, Inc. annual Cost of Revenue for 2022 was $5,481,093, a 53% decline from 2021.
Source SEC data
View on sec.gov
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

Co-Diagnostics, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $335,049 $26,285 -$271,118 -91% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $606,167 $32,106 -$180,042 -85% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $786,209 $21,590 -$212,915 -91% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $999,124 $255,068 -$2,712,773 -91% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $3,711,897 $297,403 +$41,631 +16% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $3,670,266 $212,148 -$246,947 -54% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $3,917,213 $234,505 -$267,736 -53% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $4,184,949 $2,967,841 +$2,452,067 +475% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $1,732,882 $255,772 -$512,164 -67% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $2,245,046 $459,095 -$456,337 -50% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $2,701,383 $502,241 -$2,779,710 -85% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $5,481,093 $515,774 -$1,970,995 -79% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $7,452,088 $767,936 -$2,543,319 -77% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $9,995,407 $915,432 -$1,588,923 -63% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $11,584,330 $3,281,951 +$9,386 +0.29% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $11,574,944 $2,486,769 -$1,826,251 -42% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $13,401,195 $3,311,255 -$2,510,026 -43% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $15,911,221 $2,504,355 -$3,470,950 -58% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $19,382,171 $3,272,565 +$2,790,825 +579% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $16,591,346 $4,313,020 +$4,711,763 01 Oct 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $11,879,583 $5,821,281 +$5,800,916 +28485% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $6,078,667 $5,975,305 +$5,936,496 +15297% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $142,171 $481,740 +$29,740 +6.6% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $112,431 $398,743 01 Oct 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $20,365 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q3
Q2 2019 $38,809 01 Apr 2019 30 Jun 2019 10-Q/A 03 Nov 2020 2020 Q2
Q1 2019 $452,000 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q2 2017 $302* 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018 2018 Q2

Co-Diagnostics, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $999,124 -$3,185,825 -76% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $4,184,949 -$1,296,144 -24% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $5,481,093 -$6,093,851 -53% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $11,574,944 -$5,016,402 -30% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $16,591,346 +$16,478,915 +14657% 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
2019 $112,431 +$103,040 +1097% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
2018 $9,391 +$9,089 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020 2019 FY
2017 $302* 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.